43 / 49
1. Pritchard-Jones K, Pieters R, Reaman GH, Hjorth L,
Downie P, Calaminus G, Naafs-Wilstra MC, Steliarova-
Foucher E.. Sustaining innovation and improvement
in the treatment of childhood cancer: lessons
from high-income countries. Lancet Oncol. 2013
Mar;14(3):e95-e103
2. Gatta G, Botta L, Rossi S, Aareleid T, Bielska-Lasota
M, Clavel J, Dimitrova N, Jakab Z, Kaatsch P, Lacour B,
Mallone S, Marcos-Gragera R, Minicozzi P, Sánchez-
Pérez MJ, Sant M, Santaquilani M, Stiller C, Tavilla A,
Trama A, Visser O, Peris-Bonet R; EUROCARE Working
Group. Childhood cancer survival in Europe 1999-2007:
results of EUROCARE-5--a population-based study.
Lancet Oncol. 2014 Jan;15(1):35-47. Erratum in: Lancet
Oncol. 2014 Feb;15(2):e52
3. Ferlay, J., Steliarova-Foucher, E., Lortet-Tieulent, J.,
Rosso, S., Coebergh, J., Comber, H., Forman, D. and
Bray, F. (2013). Cancer incidence and mortality patterns
in Europe: Estimates for 40 countries in 2012. European
Journal of Cancer, 49(6), pp.1374-1403
4. Kowalczyk JR, Samardakiewicz M, Fitzgerald E,
Essiaf S, Ladenstein R, Vassal G, Kienesberger A,
Pritchard-Jones K. Towards reducing inequalities:
European Standards of Care for Children with Cancer.
Eur J Cancer. 2014 Feb;50(3):481-5.
5. European Partnership for Action Against Cancer
(EPAAC), (2015). Survey report on the Standards of
Care in paediatric oncology units. [online] Available at:
http://www.epaac.eu/images/END/Final_Deliverables/D4.2_Survey_report_on_the_standards_of_care_in_
paediatric_oncology_units.pdf [Accessed 31 Jan. 2014].
6. Vassal G, Fitzgerald E, Schrappe M, Arnold
F, Kowalczyk J, Walker D, Hjorth L, Riccardi R,
Kienesberger A, Jones K, Valsecchi M, Janic D, Hasle H,
Kearns P, Petrarulo G, Florindi F, Essiaf S and Ladenstein
R. Challenges for children and adolescents with cancer
in Europe: The SIOP-Europe agenda. Pediatric Blood &
Cancer. 2014, 61(9), pp.1551-1557.
7. Vassal G, Zwaan CM, Ashley D, Le Deley MC,
Hargrave D, Blanc P, Adamson PC. New drugs for
children and adolescents with cancer: the need for
novel development pathways. Lancet Oncol. 2013
Mar;14(3):e117-24.
8. Vassal G, Rousseau R, Blanc P, Moreno L, Bode G,
Schwoch S, Schrappe M, Skolnik J, Bergman L, Bradley-
Garelik MB, Saha V, Pearson A, Zwierzina H. Creating
a unique, multi-stakeholder Paediatric Oncology
Platform to improve drug development for children
and adolescents with cancer. Eur J Cancer. 2015
Jan;51(2):218-24.
9. Ambros PF, Ambros IM, Brodeur GM, Haber M,
Khan J, Nakagawara A, Schleiermacher G, Speleman
F, Spitz R, London WB, Cohn SL, Pearson AD, Maris
JM. International consensus for neuroblastoma
molecular diagnostics: report from the International
Neuroblastoma Risk Group (INRG) Biology Committee.
Br J Cancer. 2009 May 5;100(9):1471-82.
10. Pui CH, Yang JJ, Hunger SP, Pieters R, Schrappe
M, Biondi A, Vora A, Baruchel A, Silverman LB,
SchmiegelowK, Escherich G, Horibe K, Benoit YC, Izraeli
S, Yeoh AE, Liang DC, Downing JR, Evans WE, Relling
MV, Mullighan CG. Childhood Acute Lymphoblastic
Leukemia: Progress Through Collaboration. J Clin
Oncol. 2015 Aug 24. pii: JCO.2014.59.1636. [Epub ahead
of print]
11. Schrappe M, Valsecchi MG, Bartram CR, Schrauder
A, Panzer-Grümayer R, Möricke A, Parasole R,
Zimmermann M, Dworzak M, Buldini B, Reiter A,
Basso G, Klingebiel T, Messina C, Ratei R, Cazzaniga G,
Koehler R, Locatelli F, Schäfer BW, Aricò M, Welte K,
van Dongen JJ, Gadner H, Biondi A, Conter V. Late MRD
response determines relapse risk overall and in subsets
of childhood T-cell ALL: results of the AIEOP-BFM-ALL
2000 study. Blood. 2011 Aug 25;118(8):2077-84
12. Gajjar A, Pfister SM, Taylor MD, Gilbertson RJ.
Molecular insights into pediatric brain tumors have the
potential to transform therapy. Clin Cancer Res. 2014
Nov 15;20(22):5630-40.
13. Lawrence MS, Stojanov P, Polak P, Kryukov GV,
Cibulskis K, Sivachenko A, Carter SL, Stewart C, Mermel
CH, Roberts SA, Kiezun A, Hammerman PS, McKenna
A, Drier Y, Zou L, Ramos AH, Pugh TJ, Stransky N,
Helman E, Kim J, Sougnez C, Ambrogio L, Nickerson
E, Shefler E, Cortés ML, Auclair D, Saksena G, Voet D,
Noble M, DiCara D, Lin P, Lichtenstein L, Heiman DI,
Fennell T, Imielinski M, Hernandez B, Hodis E, Baca S,
Dulak AM, Lohr J, Landau DA, Wu CJ, Melendez-Zajgla
J, Hidalgo-Miranda A, Koren A, McCarroll SA, Mora J,
References
43
A EUROPEAN CANCER PLAN FOR CHILDREN AND ADOLESCENTS